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Impaired Production and Increased Apoptosis
of Neutrophils in Granulocyte Colony-Stimulating
Factor Receptor–Deficient Mice
Fulu Liu, Huai Yang Wu, Robin Wesselschmidt, decrease in granulocytic precursors in their bone mar-
row (Lieschke et al., 1994).Tad Kornaga, and Daniel C. Link
In addition to its effect on granulopoiesis, G-CSF mayDivision of Bone Marrow Transplantation
also contribute to the regulation of multipotential hema-and Stem Cell Biology
topoietic progenitors. The administration of large dosesDepartment of Medicine
of G-CSF is associated with a dramatic increase in theWashington University Medical School
levels of hematopoietic stem cells and progenitor cellsSt. Louis, Missouri 63110-1093
in the peripheral blood (Bungart et al., 1990; de Haan
et al., 1995). In vitro, direct effects of G-CSF on primitive
progenitor cells have been demonstrated. G-CSF is able
Summary to stimulate the formation of granulocyte/macrophage
colonies (CFU-GM) from purified CD34-positiveprogeni-
We have generated mice carrying a homozygous null tors (Haylock et al., 1992). Furthermore, like interleu-
mutation in the granulocyte colony-stimulating factor kin-6 (IL-6), G-CSF exhibits synergistic activity with IL-3
to support murine multipotential blast cell colony forma-receptor (G-CSFR) gene. G-CSFR-deficient mice have
tion in cultures of spleen cells from 5-fluorouracil-decreased numbers of phenotypically normal circulat-
treated mice (Ikebuchi et al., 1988).ing neutrophils. Hematopoietic progenitors are de-
Insights into the role of hematopoietic cytokine recep-creased in the bone marrow, and the expansion and
tors in the control of hematopoiesis recently have beenterminal differentiation of these progenitors into
provided by analysisof mice carrying targeted null muta-granulocytes is impaired. Neutrophils isolated from
tions of these receptors. The erythropoietin receptor andG-CSFR-deficient mice have an increased susceptibil-
thrombopoietin receptor (c-Mpl), which like the G-CSFRity to apoptosis, suggesting that the G-CSFR may also
are predominantly expressed on cells of a single hema-regulate neutrophil survival. These data confirm a role
topoietic lineage, play crucial roles in the regulation offor the G-CSFR as a major regulator of granulopoiesis
the production of mature cells of erythroid or megakary-in vivo and provide evidence that the G-CSFR may
ocyte lineages, respectively. Erythropoietin receptor–regulate granulopoiesis by several mechanisms. How-
deficient mice die in utero secondary to a failure ofever, the data also suggest that G-CSFR-independent
definitive erythropoiesis. However, they contain normalmechanisms of granulopoiesis must exist.
numbers of committed erythroid BFU-E and CFU-E pro-
genitors, indicating that the erythropoietin receptor is
not required for erythroid lineage commitment (Wu etIntroduction
al., 1995). Likewise, thrombopoietin receptor–deficient
mice are deficient in megakaryocytes and severelyGranulopoiesis is the process whereby (in humans) ap-
thrombocytopenic, but they also have a marked defi-proximately 120 billion granulocytes are produced daily
ciency in committed megakaryocytic progenitors (Alex-from a small pool of pluripotent stem cells. Granulo-
ander et al., 1996; Gurney et al., 1994).poiesis is a regulated process; its productive capacity
To define further the role of the G-CSFR in the controlcan be increased at least 10-fold in response to certain
of granulopoiesis, we have generated a strain of micestress conditions such as infection. Granulocyte colony-
carrying a targeted null mutation in the G-CSFR genestimulating factor (G-CSF), a polypeptide growth factor,
by homologous recombination in embryonic stem (ES)appears to play a major role in regulating both basal and
cells. In this report, we show that G-CSFR-deficient micestress granulopoiesis (reviewed by Demetri and Griffin,
have decreased levels of phenotypically normal circulat-
1991). The biological effects of G-CSF are thought to
ing neutrophils. Hematopoietic progenitors are de-
be mediated through its interaction with the granulocyte
creased in the bone marrow, and the expansion and
colony-stimulating factor receptor (G-CSFR), a member terminal differentiation of these progenitors into granu-
of the cytokine receptor superfamily. Indeed, mutations locytes is impaired. Neutrophils isolated from G-CSFR-
of the G-CSFR have been implicated in the etiology of deficient mice have an increased susceptibility to
a subset of severe combined congenital neutropenia apoptosis, suggesting that the G-CSFR may regulate
(Dong et al., 1995). neutrophil survival. Our results confirm a role for the
The ability of G-CSF to stimulate granulopoiesis is G-CSFR as a major regulator of granulopoiesis in vivo
well established (Chatta et al., 1994). Multiple actions and provide evidence that the G-CSFR may regulate
of G-CSF have been described that may contribute to granulopoiesis by several mechanisms. In addition, we
the neutrophilic response. First, G-CSF stimulates the provide evidence that G-CSF may stimulate monocyte
proliferation of granulocytic precursors (Souza et al., production in a G-CSFR-independent fashion and raise
1986). Second, it reduces the average transit time the possibility that a second receptor for G-CSF exists
through the granulocytic compartment (Lord et al., 1989; on monocyte precursors.
Souza et al., 1986). Finally, G-CSF may prolong neutro-
phil survival (Colotta et al., 1992; Rex et al., 1995). The Results
importance of G-CSF to in vivo granulopoiesis was re-
cently demonstrated in mice carrying a homozygous null Targeted Disruption of the Murine G-CSFR Gene
mutation for G-CSF; these mice had approximately 20% To generate a targeted null mutation in the G-CSFR
gene, it was first necessary to clone and characterizeof normal circulating neutrophils and a corresponding
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Figure 1. Targeted Disruption of the G-CSFR
Gene
(A) Targeting strategy. The structure of the
wild-type G-CSFR locus is shownin the upper
panel, and that of the targeting vector is
shown in the central panel. Note that the
PGK–neo cassette replaces exons 3–8. The
location of the probe used to detect the wild-
type and mutated G-CSFR alleles is shown.
(B) Southern blot analysis of EcoRI-digested
genomic tail DNA isolated from progeny of
G-CSFR heterozygous mice. A 16 kb or 9.5 kb
band is detected from wild-type or targeted
alleles, respectively.
(C) Flow cytometry analysis of biotinylated
G-CSF binding to bone marrow mononuclear
cells. Cells were incubated with biotinylated
G-CSF in the absence (solid line) or presence
(broken line) of a 100-fold molar excess of
nonlabeled G-CSF followed by incubation
with PE-conjugated streptavidin. Specific
binding of biotinylated G-CSF is represented
by the difference between the two curves.
the murine G-CSFR gene. We screened a P1 library tains 4 kb of 59 targeting sequence, the neomycin phos-
photransferase gene driven by the phosphoglyceratederived from 129/Ola genomic DNA with primers specific
for murine G-CSFR. Three P1 clones were obtained. One kinase I gene promoter (PGK–neo), and 3 kb of 39 tar-
geting sequence. Homologous recombination with thisclone contained an intronless pseudogene. The other
two clones contained overlapping regions of the murine vector is expected to replace a 6 kb genomic fragment
containing exons 3 through 8 of the G-CSFR with PGK–G-CSFR gene. Mapping and sequencing studies were
performed to generate the restriction map shown in Fig- neo. The resulting targeted allele should yield no func-
tional G-CSFR protein, since the translational initiationure 1. The murine G-CSFR gene consists of 17 exons
(Figure 1A; data not shown); most of the exon–intron site, signal peptide, and G-CSF-binding domains of the
protein are removed.boundaries are conserved between the murine and hu-
man G-CSFR genes (Seto et al., 1992). The exons were RW4 ES cells (Hug et al., 1996) were electroporated,
and 240 G418-resistant clones were picked. Southernnumbered based on the human G-CSFR gene, with the
translation initiation codon located within exon 3. We blot analysis using external and internal probes yielded
a single ES clone that contained a targeted mutation ofgenerated a replacement-type targeting vector that con-
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the G-CSFR gene (data not shown). This ES clone was
injected into C57BL/6 blastocysts. Chimeric animals
were intercrossed with NIH Swiss Black mice; three of
ten chimeric animals tested were able to transmit the
G-CSFR mutation through the germline. Progeny from
heterozygous intercrosses were genotyped by Southern
blot analysis (Figure 1B). The expected numbers of
heterozygous and homozygous mutant progeny were
obtained. G-CSFR 2/2 mice develop normally, have
normal reproductive ability, and are grossly indistin-
guishable from their wild-type littermates.
Hematopoietic Cells from G-CSFR-Deficient
Mice Express No Functional G-CSFR
The expression of functional G-CSFR on hematopoietic
cells was examined using a flow cytometric method to
detect specific binding of biotinylated G-CSF. Results
are shown in Figure 1C. Specific binding of G-CSF to
bone marrow mononuclear cells was readily detected
in G-CSFR 1/1 animals. As anticipated, no G-CSF bind-
ing to G-CSFR 2/2 leukocytes was detected. Interest-
ingly, G-CSFR 1/2 animals have an intermediate level
of G-CSF binding. Similar results were obtained with
peripheral blood leukocytes (data not shown). These
data confirm that this targeted mutation of the G-CSFR
results in a null phenotype.
G-CSFR-Deficient Mice Have
Defective Granulopoiesis
G-CSFR-deficient mice are neutropenic. The results of
peripheral blood analysis are shown in Table 1. There
was no significant difference in red cell, white cell, or
platelet counts between G-CSFR 2/2 and 1/1 mice.
However, neutrophil counts in G-CSFR 2/2 mice were
approximately 12% that of 1/1 mice. A similar decrease
in splenic neutrophils was observed (data not shown),
indicating that tissue pools of neutrophils were also re-
duced. No alterations in lymphocyte or eosinophil
counts were observed. Despite the decrease in G-CSF
binding observed with leukocytes isolated from G-CSFR
1/2 mice, neutropenia was not observed in these mice.
G-CSFR 2/2 mice have decreased numbers of ma-
ture myeloid cells in their bone marrow. Examination of
hematoxylin–eosin-stained bone marrow sections from
G-CSFR 2/2 mice revealed normal cellularity and meg-
akaryocyte numbers (data not shown). In agreement
with this observation, the total number of mononuclear
cells recovered from the femurs of G-CSFR 2/2 mice
did not significantly differ from 1/1 mice (Table 2). Ma-
ture myeloid cells (metamyelocytes and granulocytes)
were decreased in G-CSFR 2/2 mice to approximately
50% that of 1/1 mice. Interestingly, no increase in my-
eloid precursor cells (myeloblasts or promyelocytes)
was seen, suggesting that there is no specific block in
myeloid differentiation. Erythroid and megakaryocytic
development appeared normal. Ta
b
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Neutrophil Emigration to Sites of Inflammation
and Myeloperoxidase Activity Are Normal We therefore further examined the phenotype of
G-CSFR 2/2 neutrophils. An important property of neu-in G-CSFR-Deficient Mice
Neutrophil function depends upon both neutrophil de- trophils is their ability to emigrate to sites of inflamma-
tion. We examined the extravasation of neutrophils intovelopment and signaling in the mature neutrophil; both
of these processes may be regulated by the G-CSFR. thioglycollate-inflamed peritoneum. Thioglycollate in-
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Table 2. Bone Marrow Analysis
Wild Type Mutant Probability
Nucleated Cell Types (Percent 6 SD) (Percent 6 SD) Value
Total nucleated cells (3 106) 33.2 6 6.4 32.2 6 7.2 NS
Myeloblasts 0.5 6 0.4 0.5 6 0.3 NS
Promyelocytes 1.8 6 0.6 1.3 6 0.3 NS
Myelocytes 2.7 6 1.0 1.9 6 0.5 NS
Metamyelocytes neutrophil 15.6 6 1.6 10.6 6 2.6 0.01
Band and segmented neutrophil 29.6 6 2.7 14.2 6 4.1 ,0.001
Eosinophil lineage 2.6 6 0.6 2.8 6 0.6 NS
Monocytes 0.2 6 0.1 0.1 6 0.1 NS
Lymphocytes and plasma cells 6.7 6 3.4 7.7 6 3.0 NS
Normoblasts 40.2 6 6.5 60.9 6 12 0.01
Myeloid/erythroid ratio 1.3 6 0.3 0.5 6 0.2 ,0.001
Cell counts and 500-count manual leukocyte differentials were performed on mononuclear cells recovered from both femurs of six sex-
matched littermates. Data represent the mean 6 SD. NS, not significant.
jection into the peritoneum induces a chemical peritoni- in response to G-CSF, suggesting that myeloperoxidase
expression may normally be regulated by G-CSFR sig-tis; neutrophils rapidly accumulate in the peritoneum
(reaching peak levels at approximately 4 hr) and then nals (Berliner et al., 1995; Rodel and Link, 1996). We
therefore examined myeloperoxidase activity in neutro-are replaced by a primarily monocytic infiltration
(Gresham et al.,1991). Neutrophils were readilydetected phils isolated from G-CSFR 2/2 mice. Neutrophils iso-
lated from the peritoneal space of thioglycollate-treatedin the peritoneal space of G-CSFR 2/2 mice 4 hr after
injection (Figure 2A). The magnitude of the neutrophil G-CSFR 2/2 mice have myeloperoxidase activity indis-
tinguishable from neutrophils isolated from wild-typeresponse, although reduced relative to G-CSFR 1/1
mice, is appropriate given the overalldecreased number littermates (Figure 2B).
of neutrophils present in the periphery and bone marrow
of G-CSFR 2/2 mice. G-CSFR-Deficient Mice Have Decreased
Numbers of Hematopoietic ProgenitorsMyeloperoxidase is a constituent of primary (azuro-
philic) granules found in myelomonocytic cells. Its ex- To define the defect in granulopoiesis in G-CSFR 2/2
mice further, we quantitated hematopoietic progenitorspression can be induced in bone marrow mononuclear
cells and in 32D cells undergoing myeloid differentiation in bone marrow and spleen. As expected, G-CSFR 2/2
Figure 2. Neutrophil Emigration and Myeloperoxidase Activity
(A) Nucleated cells were recovered from the peritoneal space 4 hr after thioglycollate injection, and 300-count manual leukocyte differentials
were performed. Fewer than 0.1 3 106 neutrophils were recovered from the peritoneum of control animals (data not shown). Eight animals of
each genotype were analyzed. Error bars represent one standard deviation from the mean.
(B) Myeloperoxidase activity. Nucleated cells were isolated from the peritoneum of thioglycollate-injected animals, as described above. Cell
lysates were prepared from samples containing equivalent numbers of neutrophils, and the myeloperoxidase activity was assayed using the
substrate Azino-bis (3-ethylbenz-thiazoline-6-sufonic acid). The increase in optical density (410 nm) over background per 104 neutrophils is
shown. No detectable myeloperoxidase activity was observed from cell preparations containing only peritoneal macrophages, lymphocytes,
and eosinophils (data not shown). The horizontal bars represent the mean of the data.
Impaired Granulopoiesis in G-CSFR-Deficient Mice
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Figure 3. Hematopoietic Progenitor Assays
(A) Bone marrow or spleen mononuclear cells were plated in methylcellulose-containing media supplemented with the indicated cytokine
(PWM, pokeweed mitogen–stimulated spleen-conditioned media). Spleen cells were stimulated with PWM. Hematopoietic colonies containing
greater than 30 cells were scored after 7–8 days. Seven animals of each genotype were analyzed. Error bars represent one standard deviation
from the mean. Probability values are shown at the bottom of the graph.
(B) Granulocyte production in hematopoietic colonies. The percentage of neutrophils was determined by manual 300-count leukocyte differen-
tials on Wright-stained cytospins of cells recovered from entire methylcellulose cultures. Cultures were stimulated with the indicated cytokine
for 8 days.
(C) Macrophage production in hematopoietic colonies. The percentage of macrophages was determined as described above. With G-CSFR
2/2 bone marrow cells, a significant increase in the percentage of macrophages was observed in cultures stimulated with IL-6 plus G-CSF
versus IL-6 alone (p < 0.02).
bone marrow cells produced no hematopoietic colonies Figure 3B and Figure 4A). We therefore examined the
in response to G-CSF (Figure 3A). Relative to G-CSFR effect of the addition of G-CSF to IL-6 upon hematopoi-
1/1 mice, we detected a modest but significant reduc- etic colony formation. In cultures of G-CSFR 1/1 bone
tion in the total number of hematopoietic colonies marrow cells, an identical number of hematopoietic col-
formed in response to pokeweed mitogen–stimulated onies formed in response to G-CSF alone, IL-6 alone,
spleen-conditioned media, IL-3, granulocyte/macro- or the combination of G-CSF and IL-6, suggesting that
phage colony-stimulating factor (GM-CSF), or stem cell G-CSF and IL-6 are stimulating an identical population
factor. These data demonstrate that the G-CSFR is re- of hematopoietic progenitors (Figure 3A). The addition
quired for the maintenance of a normal number of hema- of G-CSF did, however, stimulate an increase in colony
topoietic progenitors. size and in the percentage of mature neutrophils pro-
duced in these colonies (Figure 3B), indicating that
G-CSF can stimulate the expansion and terminal differ-
A Basal G-CSFR-Independent Mechanism for
entiation of these committed myeloid progenitors.the Production of Mature Granulocytes
from Hematopoietic Progenitors Exists
The presence of phenotypically normal neutrophils in
Neutrophils from G-CSFR-Deficient Mice HaveG-CSFR-deficient mice suggested that G-CSFR-inde-
Increased Susceptibility to Apoptosispendent mechanisms of granulopoiesis must exist. To
The relative abundance of mature granulocytes in thecharacterize these mechanisms, we examined theability
marrow compared with peripheralcirculation inG-CSFR-of hematopoietic progenitors from G-CSFR-deficient
deficient mice suggested either that neutrophil emigra-mice to produce granulocytes in response to various
tion from the bone marrow was impaired or that neutro-cytokines. As shown in Figure 3B, mature granulocytes
phil survival was reduced. G-CSF has been shown towere detected in all cultures regardless of the stimulat-
prolong neutrophil survival by suppressing apoptosising cytokine. Interestingly, the percentage of neutrophils
(Colotta et al., 1992; Martin et al., 1995; Rex et al., 1995).produced in cultures stimulated with IL-3 or GM-CSF
We therefore examined freshly isolated peripheral bloodwas similar between 2/2 and 1/1 mice, suggesting
and bone marrow mononuclear cells for evidence ofthat a basal G-CSFR-independent mechanism for the
apoptosis. Apoptosis was assessed by Annexin V bind-production of mature granulocytes from hematopoietic
ing to surface-expressed phosphatidylserine, a sensi-progenitors exists.
tive and early marker of apoptosis (Homburg et al., 1995;In cultures of both G-CSFR 1/1 and 2/2 hematopoi-
Koopman et al., 1994; Martin et al., 1995). As shown inetic progenitors, IL-6-stimulated colonies consisted pri-
Figure 5, no evidence for a significant population ofmarily of granulocytic cells (although IL-6-stimulated
colonies contained many immature granulocytic cells; apoptotic cells was detected in freshly isolated bone
Immunity
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Figure 4. Morphology of Cells Recovered from Hematopoietic Colonies
Wright stain of cells recovered from methylcellulose cultures of G-CSFR 1/1 (A and B) or 2/2 (C and D) progenitors stimulated with the
indicated cytokine for 8 days. IL-6-stimulated hematopoietic colonies were made up predominantly of immature myeloid cells (large arrows
in [A] and [C]). The addition of G-CSF stimulated the production of mature granulocytes (small arrows) in cultures of G-CSFR 1/1 bone
marrow cells (B). In contrast, a significant increase in the percentage of macrophages (arrowheads) was detected in hematopoietic colonies
generated from G-CSFR 2/2 progenitors stimulated with G-CSF and IL-6 ([D] and see Figure 3C).
marrow fromG-CSFR-deficient animals.However, apop- peripheral blood monocytes by flow cytometry
(CD11b1/GR-12 cells; see Table 1) and by manual differ-totic cells may be rapidly cleared in vivo by the reticulo-
endothelial system. We therefore examined neutrophil entials of blood smears (data not shown). In contrast
with G-CSF (ligand)-deficient mice, which have periph-survival in vitro. Bone marrow mononuclear cells were
cultured in serum-containing media with or without eral blood monocyte numbers approximately 50% that
of wild-type mice, G-CSFR-deficient mice have a relativeG-CSF. After 48 hr, 31% of Gr-1-positive (myeloid) cells
from G-CSFR 1/1 mice were apoptotic. In agreement monocytosis with peripheral blood monocyte numbers
approximately 150% that of wild-type mice. We postu-with previous work, the addition of G-CSF to these cul-
tures was able to suppress neutrophil apoptosis sub- lated that this phenotypic difference may be secondary
to endogenous G-CSF stimulation of monocytopoiesisstantially. In contrast, incultures with G-CSFR 2/2 bone
marrow cells, 68% of Gr-1-positive cells were apoptotic in G-CSFR-deficient mice. To examine this hypothesis
further, we stimulated mice (n 5 8) with 250 mg/kg perat 48 hr, and no response to G-CSF was noted, as ex-
pected. The modest increase in the percentage of apop- day of human G-CSF for 5 days and measured their
leukocyte responses. Wild-type mice had the expectedtotic cells in the Gr-1-negative fraction of G-CSFR 2/2
compared with G-CSFR 1/1 cultures suggests that a increase in circulating neutrophils (11.6 6 6.8-fold in-
crease over baseline) and monocytes (2.71 6 0.99-foldminority of Gr-1-negative cells may also have a pro-
longed survival in response to G-CSF. This increased increase over baseline). In contrast, no significant in-
crease in circulating neutrophils (1.36 6 0.55-fold in-susceptibility to apoptosis is not secondary to mouse
strain differences, since a similar percentage of apop- crease over baseline) or monocytes (1.39 6 1.07-fold
increase over baseline) was detected after G-CSF stimu-totic cells was observed in cultures of bone marrow
cells isolated from Swiss Black or 129/Sv mice (data not lation of G-CSFR-deficient mice. We reasoned that this
lack of response to G-CSF might be due to the chronicshown). These data demonstrate that neutrophils from
G-CSFR-deficient mice have an increased susceptibility stimulation of monocytopoiesis by endogenous G-CSF
in these mice. We therefore examined the ability ofto apoptosis and suggest that the G-CSFR may play a
role in regulating neutrophil survival. G-CSF to stimulate monocyte production from G-CSFR
2/2 hematopoietic progenitors. As noted above, G-CSF
and IL-6 appear to stimulate an identical populationEvidence That G-CSF Can Stimulate Monocyte
Production in a G-CSFR-Independent Fashion of hematopoietic progenitors; with G-CSFR 1/1 bone
marrow cells, the major effect of the addition of G-CSFIn addition to its effects on granulopoiesis, G-CSF is also
able to stimulate monocyte production. We quantitated to IL-6-stimulated cultures is the increased production
Impaired Granulopoiesis in G-CSFR-Deficient Mice
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Figure 5. Apoptosis of Neutrophils in Culture
Bone marrow mononuclear cells were cultured in serum-containing media with or without G-CSF for 48 hr. At the indicated time, cells were
harvested, stained with Annexin V (an early marker of apoptosis) and Gr-1 (a granulocyte-specific marker), and analyzed by flow cytometry.
The percentage of cells present in each quadrant is indicated. With G-CSFR 1/1 bone marrow cells, 31% of the Gr-1-positive cells are
Annexin V positive (apoptotic) after 48 hr in culture without G-CSF; with G-CSF, this percentage decreased to 18%. In contrast, with G-CSFR
2/2 bone marrow cells, 68% of the Gr-1-positive cells are Annexin V positive after 48 hr in culture, and no response to G-CSF was observed.
of mature granulocytes. In contrast, the addition of stimulate monocyte production in a G-CSFR-indepen-
dent fashion.G-CSF to IL-6-stimulated cultures of G-CSFR 2/2 pro-
genitors reproducibly increased the percentage of Severe combined neutropenia (SCN) is a rare congeni-
tal disorder manifested by neutropenia and an arrest ofmacrophages produced in these colonies (Figures 3C
and 4), demonstrating that, in vitro, G-CSF can stimu- myeloid maturation at the promyelocyte or myelocyte
stage (Kostmann, 1956). It has been hypothesized thatlate monocyte production in a G-CSFR-independent
fashion. the defect in granulopoiesis observed in this syndrome
is secondary to a defect in G-CSFR signaling (Dong et
al., 1995). Our data do not support this hypothesis. NoDiscussion
accumulation of early myeloid precursors was detected
in G-CSFR 2/2 mice. It remains formally possible thatIn this study, we have generated homozygous mice car-
abnormal signaling through the G-CSFR, as opposed torying a null mutation in the G-CSFR gene. Analysis of
the absence of G-CSFR signaling, could produce theG-CSFR-deficient mice confirms the hypothesis in the
SCN phenotype.literature that the G-CSFR is a major regulator of granul-
opoiesis: G-CSFR-deficient mice have defective granul-
opoiesis with chronic neutropenia and a decrease in Role of the G-CSFR in Granulopoiesis
The ability of G-CSF to stimulate granulopoiesis is wellmature myeloid elements in their bone marrow. We pro-
vide evidence that the G-CSFR may regulate granulo- documented. Multiple mechanismshave been proposed
to mediate this effect, including the stimulation of primi-poiesis by several mechanisms. G-CSFR-deficient mice
have decreased numbers of hematopoietic progenitors, tive hematopoietic progenitors, proliferation of commit-
ted granulocytic precursors, and the facilitation of gran-and the expansion and terminal differentiation of these
progenitors into granulocytes is impaired. Further, we ulocytic maturation. The biological importance of these
activities is not clear. Our study now shows thatshow that neutrophils isolated from G-CSFR-deficient
mice have an increased susceptibility to apoptosis, sug- G-CSFR-deficient mice have a modest reduction in the
number of hematopoietic progenitors. In addition togesting that the G-CSFR may also regulate neutrophil
survival. Finally, we provide evidence that G-CSF may regulating hematopoietic progenitor cell number, the
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G-CSFR also appears to regulate the production of ma- receptor complex initiate similar signal transduction
cascades (Kishimoto et al., 1995). Indeed, the G-CSFRture granulocytes from individual progenitors. The addi-
tion of G-CSF to IL-6-stimulated hematopoietic cultures and gp130 (the signal transduction subunit of the IL-6
receptor complex) share significant homology withinsignificantly increased the number of mature granulo-
cytes. This effect does not appear to be secondary to their cytoplasmic domains. It is interesting to note that,
in the present study, the hematopoietic colonies thatthe stimulation of additional hematopoietic progenitors,
since the total number of colonies formed in response formed in response to IL-6 were made up primarily of
granulocytic cells. Studies are underway to examineto IL-6 alone, G-CSF alone, and the combination of IL-6
plus G-CSF was not significantly different. granulopoiesis in mice deficient for both the G-CSFR
and IL-6.The hypothesis that the G-CSFR transmits granulo-
cytic differentiation signals to hematopoietic progeni-
tors is controversial (reviewed by D’Andrea, 1994). This The G-CSFR May Regulate Neutrophil Survival
hypothesis predicts that granulopoiesis in the absence In Vivo by Controlling Their Rate
of these signals might lead to functionally defective neu- of Apoptosis
trophils. No such abnormalities were detected in the The ability of cytokines to suppress apoptosis in target
neutrophils produced in G-CSFR-deficient mice. Neu- cells is well documented (Williams et al., 1990). In partic-
trophil morphology and surface expression of the my- ular, G-CSF (along with several other cytokines) is able
eloid antigens Gr-1 and CD11b were normal (data not to suppress apoptosis and prolong neutrophil survival
shown). In addition, no defect in theability of neutrophils in vitro (Colotta et al., 1992). Recent evidence suggests
from G-CSFR 2/2 to emigrate to sites of inflammation that this ability may be biologically significant; erythro-
was detected. Myeloperoxidase expression, thought to poietin- and erythropoietin receptor–deficient mice
be linked to G-CSFR signals (Berliner et al., 1995; Rodel demonstrate increased apoptosis of their erythroid pro-
and Link, 1996), was also normal in G-CSFR-deficient genitors (Wu et al., 1995). In this study, we show that
neutrophils. These neutrophil functional tests are not neutrophils isolated from G-CSFR-deficient mice have
comprehensive, and significant defects in neutrophil an increased susceptibility to apoptosis in vitro. A signif-
function may have been missed; however, these data icant population of apoptotic neutrophils was not de-
provide evidence that the G-CSFR is not required for tected in freshly isolated bone marrow; however, the
the development of functionally normal neutrophils. This rapid clearance of such cells by the reticuloendothelial
observation suggests two possibilities: either granulo- system may preclude their detection. Two recent reports
cyte lineage commitment and differentiation is a sto- indicate that the administration of large doses of G-CSF
chastic process that occurs independently of cytokine in vivo does not affect neutrophil half-life (Lord et al.,
signals, or the lineage commitment signals provided by 1991; Price et al., 1996). It is possible that baseline levels
the G-CSFR are redundant. of endogenous G-CSF are sufficient to suppress neutro-
We show that hematopoietic progenitors from G-CSFR- phil apoptosis during normal granulopoiesis. Further-
deficient mice are capable of producing mature granulo- more, G-CSF may play a significant role in regulating
cytes in culture; in fact, all cytokines tested (with the neutrophil survival during episodes of infection or other
exception of G-CSF) were able to support the growth stresses when inflammatory mediators may be affecting
and differentiation of granulocytes. This result is consis- neutrophil survival.
tent with the hypothesis that commitment to the granulo-
cyte lineage is a stochastic process that occurs inde-
G-CSF Stimulates Monocyte Productionpendently of cytokines. However, it is also possible that
in a G-CSFR-Independent Fashiona factor(s) produced in common by cells in these cul-
In addition to its effects on granulopoiesis, G-CSF istures is providing alternative signals for granulocyte lin-
also able to stimulate monocytopoiesis. In mice, thiseage commitment. Several hematopoietic cytokines
effect appears to be due to a stimulation of the prolifera-apart from G-CSF are known to affect granulopoiesis,
tion of monocyte precursors (Lord et al., 1989). A recentand they are potential candidates to provide the neces-
report suggested that the stimulation of monocyto-sary granulocyte lineage commitment signals. Micedefi-
poiesis by G-CSF is indirect and may be mediated bycient for both G-CSF and GM-CSF have recently been
CSF-1 (Gilmore et al., 1995). However, specific (albeitgenerated (Seymour et al., 1995). Peripheral blood gran-
low level) binding of G-CSF to monocyte and monocyteulocyte and monocyte counts in these mice were identi-
precursors also has been demonstrated (Nicola andcal to G-CSF-deficient mice, suggesting that GM-CSF
Metcalf, 1985). In this study, we demonstrate that theis not solely responsible for the residual granulopoiesis
G-CSFR-deficient mice have a resting monocytosis (ain G-CSF-deficient mice. IL-6 is a multifunctional cyto-
typical finding in many patients with neutropenia). Inkine that has diverse biological effects on hematopoietic
contrast, the G-CSF (ligand)-deficient mice have a rest-cells (Kishimoto et al., 1995). Recent data suggest that
ing monocytopenia. It is possible that this difference inIL-6 may play a role in the regulation of granulopoiesis.
monocytopoiesis is due to strain differences in the miceAlthough IL-6-deficient mice have normal steady-state
used in these studies (G-CSFR, 129/Sv 3 Swiss Black;granulopoiesis, they are unable to mount a neutrophilic
G-CSF [ligand], 129/Sv 3 C57BL/6). However, we de-response to Listeria monocytogenes infection (Dalrym-
tected no difference in baseline levels of circulatingple et al., 1995). This observation is consistent with stud-
monocytes between 129/Sv and Swiss Black mice (dataies in which the administration of recombinant IL-6 to
not shown). It is also possible that G-CSF is stimulatingmice inducedan increase in peripheral neutrophil counts
(Ulich et al., 1989). Interestingly, the G-CSFR and IL-6 monocyte production in the G-CSFR-deficient mice. In
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intercrossed with NIH Swiss Black mice (Taconic), and germlinesupport of this hypothesis, G-CSF in combination with
transmission of the mutant allele was detected by Southern blotIL-6 was able to stimulate monocyte production from
analysis of tail DNA from agouti F1 offspring. All mice were housedG-CSFR-deficient progenitors. The lack of a significant
in a transgenic barrier environment and examined daily by the veteri-
increase in levels of circulating monocytes in the nary staff for signs of illness. A single G-CSFR-deficient mouse
G-CSFR-deficient mice in response to G-CSF may be developed a pyogenic infection at the site of its ear tag and was
euthanized.secondary to the chronic stimulation of monocyto-
poiesis by endogenous G-CSF. We arecurrently working
on an assay to measure endogenous G-CSF levels in
Peripheral Blood, Bone Marrow, and Histological Analysis
our G-CSFR-deficient mice. Collectively, these intri- Blood was obtained by retro-orbital venous plexus sampling in poly-
guing data suggest that G-CSF may stimulate monocyt- propylene tubes containing EDTA. Complete blood counts were
determined using a Baker-1000 automated cell counter. Bone mar-opoiesis in a G-CSFR-independent fashion and raise
row was harvested by flushing both femoral bones with 3 ml ofthe possibility that a second receptor for G-CSF exists
a-MEM containing 2% fetal bovine serum (FBS). Spleen cell suspen-on monocyte precursors. Confirmation of this hypothe-
sions were obtained by homogenizing portions of spleen in a-MEMsis will require a definitive demonstration that G-CSF
containing 2% FBS. Leukocyte differentials were performed on
can stimulate monocytopoiesis in vivo in a G-CSFR- Wright-stained blood smears or cytospins of purified leukocyte
independent fashion. To this end, experiments are preparations. For histology, formalin-fixed tissues were paraffin em-
bedded, sectioned, and stained with hematoxylin–eosin.planned to study monocytopoiesis in mice deficient for
both the G-CSF (ligand) and G-CSFR.
In summary, we have confirmed that the G-CSFR is
Flow Cytometry
a major regulator of granulopoiesis in vivo. However, Red blood cells in peripheral blood and bone marrow mononuclear
the production of phenotypically normal neutrophils in cell preparations were lysed in Tris-buffered ammonium chloride
(pH 7.2) buffer and incubated with the indicated antibody at 48C forG-CSFR-deficient animalsdemonstrates that a G-CSFR-
1 hr in PBS containing 0.1% sodium azide and 5% rat serum to blockindependent mechanism(s) of granulopoiesis also ex-
nonspecific binding. The following directly conjugated monoclonalists. Our results indicate that the G-CSFR may regu-
antibodies were used: phycoerythrin (PE)-conjugated rat anti-late granulopoiesis by several mechanisms. First, the
mouse CDllb (M1/70, IgG2b; Pharmingen); fluorescein isothiocya-
G-CSFR appears to play a significant role in the regula- nate (FITC)-conjugated rat anti–mouse Gr-1 (RB6-8C5, IgG2b;
tion of the production of committed myeloid precursors Pharmingen); PE-conjugated rat IgG2b (R35-38, isotype control;
Pharmingen); and FITC-conjugated rat IgG2b (R35-38, isotype con-from more primitive hematopoietic progenitors. Second,
trol; Pharmingen). To assess surface G-CSFR expression, G-CSFit affects the expansion and terminal maturation of com-
was biotinylated using NHS-LC-biotin (Pierce) as previously de-mitted granulocytic precursors. Finally, theG-CSFR may
scribed (Shimoda et al., 1992). Peripheral blood mononuclear cellsplay a significant role in the regulation of neutrophil
were incubated at 48C for 1 hr with biotinylated G-CSF (25 ng per
survival. In addition, we provide evidence that G-CSF 106 cells) in the presence or absence of a 100-fold molar excess
may stimulate monocyte production in a G-CSFR- of nonlabeled G-CSF, followed by incubation with PE-conjugated
streptavidin. All cells were analyzed on a FACScan flow cytometer.independent fashion and raise the possibility that a sec-
ond receptor for G-CSF exists on monocyte precursors.
Thioglycollate-Induced Peritonitis
Experimental Procedures and Myeloperoxidase Activity
Mice were injected intraperitoneally with 2 ml of thioglycollate broth
Construction of G-CSFR Targeting Vector (DIFCO), and peritoneal lavage was performed 4 hr later. Red blood
A P1 genomic library (Genome Systems) from the 129/Ola mouse cells were lysed in Tris-buffered ammonium chloride (pH 7.2) buffer,
strain was screened with primers specific for murine G-CSFR: for- and leukocytes were enumerated using a Coulter counter (model
ward primer from exon 5 (59-CTGCCAGCCCCTCAAACCTATC-39) F) automated counter. Leukocyte differentials were performed on
and reverse primer from exon 6 (59-ATGGGGTCGAGGCACAG Wright-stained cytospins. Neutrophil myeloperoxidase activity was
CTT-39). Genomic fragments were subcloned intopBluescript (Strat- assayed using these leukocyte preparations. Samples containing
agene). The 4 kb KpnI and 3 kb BamHI–HindIII (blunt, NotI linkered) equivalent numbers of neutrophils were lysed and assayed for my-
genomic fragments were inserted 59 and 39, respectively, of the 1.8 eloperoxidase activity using the substrate Azino-bis (3-ethylbenz-
kb PGK–neor cassette (see Figure 1A). The final 12 kb construct thiazoline-6-sufonic acid) (Sigma) as previously described (Parkos
was linearized with NsiI before transfection. et al., 1991).
Transfection, Selection of ES Clones, and Southern
Blot Analysis Hematopoietic Progenitor Cell Assays
RW4 ES cells (a gift from R. Wesselschmidt and T. J. Ley) were Bone marrow or spleen mononuclear cells were enumerated using
cultured on mitotically inactivated mouse embryonic fibroblasts in a hemacytometer. We plated 2 3 104 bone marrow mononuclear
standard ES medium. ES cells were electroporated (185 V, 500 mF) cells or 1 3 105 spleen mononuclear cells in either 1 ml of methylcel-
with 25 mg of linearized G-CSFR targeting vector and cultured on lulose media (MethoCult M3230, Stem Cell Technologies) supple-
mouse embryonic fibroblast cells resistant to G418. After 24 hr, the mented with the indicated cytokines or with 1 ml of methylcellulose
medium was supplemented with 400 mg/ml G418 (GIBCO BRL), and media supplemented with erythropoietin and pokeweed mitogen–
120 ES clones from each electroporation were isolated after 6–7 stimulated murine spleen cell–conditioned medium (MethoCult
days of selection. Individual clones were expanded, and genomic M3430, Stem Cell Technologies). Colonies were counted on days
DNA was prepared. DNAs were digested with EcoRI, resolved on 7–8. Recombinant cytokines were used at the following concentra-
0.8% agarose gels, and transferred to nitrocellulose filters. Filters tions: G-CSF, 10 ng/ml (Amgen); GM-CSF, 10 ng/ml (R&D Systems);
were hybridized with 32P-labeled probe A (Figure 1B). IL-3, 10 ng/ml (R&D Systems); IL-6, 500 ng/ml (R&D Systems); and
stem cell factor, 100 ng/ml (R&D Systems). To examine cell morphol-
ogy, entire methylcellulose cultures were harvested and washedGeneration of Germline Chimeras
The ES clone containing the null mutation was sent to the University extensively to remove the methylcellulose. Leukocyte differentials
were performed on Wright-stained cytospins of the hematopoieticof Cincinnati Medical Center ES cell gene altered mouse service
core for injection into C57BL/6 blastocysts. Chimeric animals were cells.
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Apoptosis Assay to prolonged increased mature blood cell production induced by
granulocyte colony-stimulating factor. Blood 86, 2986–2992.Bone marrow cells were sterile harvested, as described above, into
a-MEM with 5% FBS, 1 mM L-glutamine, and 10 mg/ml ciprofloxacin Demetri, G.D., and Griffin, J.D. (1991). Granulocyte colony-stimulat-
(Bayer). Cells were cultured in tissue-culture flasks at 378C in 5% ing factor and its receptor. Blood 78, 2791–2808.
CO2 for 1 hr to remove adherent cells (including macrophages). The Dong, F., Brynes, R.K., Tidow, N., Welte, K., Lowenberg, B., andnonadherent cells were harvested and either analyzed as described
Touw, I.P. (1995). Mutations in the gene for the granulocyte colony-below or cultured for an additional 48 hr. Where indicated the culture
stimulating-factor receptor in patients with acute myeloid leukemiawas supplemented with 100 ng/ml G-CSF. For analysis, cells were
preceded by severe congenital neutropenia. N. Engl. J. Med. 333,washed once in a-MEM, once in binding buffer (20 mM HEPES, 132
487–493.mM NaCl,6 mM KCl, 0.8 mM CaCl2, 1 mM MgSO4, 1.2 mM potassium
Gilmore, G., DePasquale, D., Fischer, B., and Shadduck, R. (1995).phosphate, 5.5 mM glucose, and 0.5% bovine serum albumin [pH
Enhancement of monocytopoiesis by granulocyte colony-stimulat-7.4]) and then resuspended at 1 3 107 cells per milliliter in binding
ing factor: evidence for secondary cytokine effects in vivo. Exp.buffer. Cells (106) were incubated with FITC-conjugated Annexin V
Hematol. 23, 1319–1323.(NeXins Research B. V.) and PE-conjugated rat anti–mouse Gr-1 for
30 min at 48C, washed twice in binding buffer, and analyzed on a Gresham, H.D., Ray, C.J., and O’Sullivan, F.X. (1991). Defective neu-
FACScan flow cytometer. trophil function in the autoimmune mouse strain MRL/lpr: potential
role of transforming growth factor-b. J. Immunol. 146, 3911–3921.
G-CSF Administration to Mice Gurney, A.L., Carver-Moore, K., Sauvage, F.J.d., and Moore, M.W.
Recombinant human G-CSF (Amgen) was administered by daily (1994). Thrombocytopenia in c-mpl-deficient mice. Science 265,
subcutaneous injection at a dose of 250 mg/kg per day for 5 days. 1445–1447.
Peripheral blood was obtained before the first G-CSF dose and 4–6
Haylock, D.N., To, L.B., Dowse, T.L., Juttner, C.A., and Simmons,
hr after the final G-CSF dose. Peripheral blood leukocyte levels were
P.J. (1992). Ex vivo expansion and maturation of peripheral blood
analyzed as described above. A total of eight G-CSFR 1/1 and
CD341 cells into the myeloid lineage. Blood 80, 1405–1412.
eight G-CSFR 2/2 mice were studied in two separate experiments.
Homburg, C.H.E., Haas, M.d., Borne, A.E.G.K.v.d., Verhoeven, A.J.,No leukocyte responses were detected in control (saline-injected)
Reutelingsperger, C.P.M., and Roos, D. (1995). Human neutrophilsmice (data not shown).
lose their surface FcgRIII and acquire Annexin V binding sites during
apoptosis in vitro. Blood 85, 532–540.Statistical Analysis
Hug, B.A., Wesselschmidt, R.L., Fiering, S., Bender, M.A., Epner, E.,Data are presented as mean 6 SD. Statistical significance was as-
Groudine, M., and Ley, T.J. (1996). Analysis of mice containing asessed by Student’s t test.
targeted deletion of b-globin locus control region 59 hypersensitive
site 3. Mol. Cell. Biol. 16, 2906–2912.Acknowledgments
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